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Deletion of Nedd4-2 results in progressive kidney
disease in mice
Tanya L Henshall1,4, Jantina A Manning1,4, Omri S Alfassy1,4, Pranay Goel1,2,4, Natasha A Boase1, Hiroshi Kawabe3 and
Sharad Kumar*,1,2
NEDD4-2 (NEDD4L), a ubiquitin protein ligase of the Nedd4 family, is a key regulator of cell surface expression and activity of the
amiloride-sensitive epithelial Na+ channel (ENaC). While hypomorphic alleles of Nedd4-2 in mice show salt-sensitive hypertension,
complete knockout results in pulmonary distress and perinatal lethality due to increased cell surface levels of ENaC. We now show
that Nedd4-2 deficiency in mice also results in an unexpected progressive kidney injury phenotype associated with elevated ENaC
and Na+Cl− cotransporter expression, increased Na+ reabsorption, hypertension and markedly reduced levels of aldosterone. The
observed nephropathy is characterized by fibrosis, tubule epithelial cell apoptosis, dilated/cystic tubules, elevated expression of
kidney injury markers and immune cell infiltration, characteristics reminiscent of human chronic kidney disease. Importantly, we
demonstrate that the extent of kidney injury can be partially therapeutically ameliorated in mice with nephron-specific deletions of
Nedd4-2 by blocking ENaC with amiloride. These results suggest that increased Na+ reabsorption via ENaC causes kidney injury
and establish a novel role of NEDD4-2 in preventing Na+-induced nephropathy. Contrary to some recent reports, our data also
indicate that ENaC is the primary in vivo target of NEDD4-2 and that Nedd4-2 deletion is associated with hypertension on a normal
Na+ diet. These findings provide further insight into the critical function of NEDD4-2 in renal pathophysiology.
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Na+ homeostasis in the kidney is critical for themaintenance of
blood volume and blood pressure (BP). The Na+ reabsorption
in the nephron is mediated via the Na+Cl− co-transporter
(NCC) in the distal convoluted tubule (DCT), and through
the amiloride-sensitive epithelial Na+ channel (ENaC) in the
connecting tubule (CNT), distal tubule (DCT) and the
collecting duct (CD). Both NCC and ENaC are regulated by
the ubiquitin protein ligase, NEDD4-2.1–5 Although NEDD4-2
is known to ubiquitinate and regulate the expression of many
cell surface proteins, the most studied targets of NEDD4-2 are
the three subunits (α, β and γ) of ENaC. The WW domains of
NEDD4-2 have been demonstrated to directly bind to the
PPxY motifs present in the cytoplasmic C termini of all three
ENaC subunits leading to their ubiquitination, endocytosis and
degradation.2,3 Thus, an expected consequence of the loss of
Nedd4-2 is increased cell surface expression and membrane
retention of ENaC, resulting in increased ENaC activity.1 The
significance of NEDD4-2-dependent regulation of ENaC in the
maintenance of Na+ homeostasis is apparent from Liddle’s
syndrome, characterized by constitutively elevated ENaC
activity and hypertension due to mutations in the PY motifs of
β- and γ-ENaC, which abrogate the interaction between ENaC
and NEDD4-2.2
NEDD4-2 is widely expressed during mouse development
and in adult tissues, with particularly high expression in the
liver, kidney, heart, brain and lung.1,6 The studies of Nedd4-2
knockout (KO) mice have provided useful and also somewhat
unexpected and contradictory insights into the in vivo function
of NEDD4-2. A Nedd4-2 KO mouse line (Nedd4-2 Δ exons
6–8, which includes an alternative translation start site and
WW domain 1) express small amounts of Nedd4-2 splicing
isoforms.7 These mice appear normal but show slightly
increased ENaC expression and hypertension upon feeding
a high-salt diet.7 A renal-tubule-specific Nedd4-2 conditional
KO mouse with the same mutation (Nedd4LPax8/LC1) demon-
strated that hypertension is largely due to increased expres-
sion and activity of theNCC.8 Recently, it was shown that α and
γ (but not β) ENaC levels are increased when these mice are
fed a long-term, low K+ diet.9
A KO line generated in our laboratory in which all Nedd4-2
splicing variants are absent (Nedd4-2 Δ exons 15–16) display
increased ENaC expression in the lung and kidney, with
perinatal death of animals due to respiratory distress as a
result of failure of lungs to inflate, or severe sterile inflamma-
tion of the lung.5 The different severity of the phenotypes
between these lines is likely due to the hypomorphic nature of
the Nedd4-2 Δ exons 6–8 allele. This is supported by studies
with another independent line where Nedd4-2 KO results in
perinatal death,10 and a conditional KO of Nedd4-2 in the lung
that was found to be sufficient for animals to develop
inflammatory lung disease, leading to perinatal lethality.10
To determine the effect of Nedd4-2 loss in the kidney, we
analyzed the pathology of Nedd4-2 Δ exons 15–16 mice. We
report here that Nedd4-2 loss results in progressive kidney
damage beginning immediately after birth. Additionally, we
confirm this pathology in a kidney tubule-specific Nedd4-2 KO
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mouse line, Nedd4-2Ksp1.3. We further show that increased
ENaC activity contributes to the observed kidney damage.
We therefore provide the first evidence that loss of Nedd4-2
results in early and progressive kidney damage. Given our
demonstration of a direct and critical role for ENaC in renal
injury, ourNedd4-2KOmice can be a valuable resource for the
study of the effects of salt on progression of kidney damage.
Results
Nedd4-2−/− kidney pathology consistent with kidney
damage. We have previously described a perinatal lethal
phenotype of Nedd4-2−/− mice due to respiratory distress;
however, a small percentage of animals survive up to 3 weeks
of age.5 To determine the role of NEDD4-2 in the kidney, we
carried out pathological analysis of kidneys from wild-type
and surviving Nedd4-2−/− mice at postnatal (P) day 20.
Kidneys from Nedd4-2−/− mice appeared pale and showed
histological changes consistent with renal damage, including
a disorganized structure and numerous cortical cysts with
necrotic cellular debris, often with luminal stenosis/obstruc-
tion (Figure 1a). Large areas of mesenchyme were observed
by histology, immunohistochemistry and real-time quantita-
tive PCR (qRT-PCR) for the mesenchymal marker, vimentin
(Figures 1b and c). In addition, Nedd4-2−/− kidneys showed
obvious fibrotic damage occupying a large portion of the
cortex revealed by immunohistochemistry and qRT-PCR for
α-1 type 1 collagen. Consistent with kidney injury, expression
of the myofibroblast marker, α-smooth muscle actin (SMA),
and marker for proximal tubule kidney injury, kidney injury
molecule-1 (KIM-1, also referred to as T-cell immunoglobulin
mucin (TIM-1),11 was upregulated in Nedd4-2−/− kidneys
compared with wild type at P20 (Figures 1b and c).
Time-course analysis revealed normal kidney histology at
embryonic day (E) 18.5, with damage becoming evident by
P3 and progressing in severity until death at ~P20 (Supple-
mentary Figure 1). The lack of kidney pathology at E18.5
suggests that kidney development occurs normally in Nedd4-
2-deficient mice.
Generation of renal-tubule-specific Nedd4-2-deficient
mice. After identifying a critical new role for NEDD4-2 in
renal homeostasis, we next aimed to investigate the
progression of kidney injury beyond 20 days. To this end,
we generated a renal-tubule-specific Nedd4-2 KO mouse line
by crossing a previously generated Nedd4-2fl/fl mouse line
(with ablation of Nedd4-2 exon 15 onward, resulting in the
absence of the catalytic HECT domain and a complete loss of
Nedd4-2 protein)10 to the Ksp1.3-Cre transgene line.12
Ksp-cadherin, also called cadherin-16, has a well-character-
ized, kidney-specific expression in renal epithelial cells of the
collecting ducts, loop of Henle, the majority of proximal
tubules and in some distal tubules.13 Therefore, Ksp1.3-Cre;
Nedd4-2fl/fl blocks NEDD4-2 expression in cadherin-16-
positive cells and is hereafter referred to as Nedd4-2Ksp1.3.
Immunoblot analysis of whole kidney lysates from this strain
showed a decrease in NEDD4-2 protein compared with
control kidneys (Cre negative) at P40 (Figure 2a). This was
quantitated to an average reduction of ~ 50% (Figure 2b).
Remaining NEDD4-2 is likely due to expression within the
glomerulus, blood vessels and any other cells that do not
express cadherin-16, but express NEDD4-2.12,13 Immuno-














































































































Figure 1 Loss of NEDD4-2 results in kidney injury in juvenile mice. (a)
Representative images showing hematoxylin–eosin (H&E) staining. Pathological
observations include enlarged tubules (*), cellular debris within tubules (arrows) and
mesenchyme infiltration (arrowheads). (b) Immunostaining shows increased
expression of vimentin (mesenchymal marker), (SMA; myofibroblasts) and KIM-1
(marker of proximal tubule kidney injury). Picrosirius red staining demonstrates
fibrosis in Nedd4-2−/− kidneys. (c) Increased gene expression for markers of kidney
pathology, including collagen (encoded by Col1a1), vimentin (Vim), SMA (Acta2) and
Kim-1, as determined by qRT-PCR in Nedd4-2+/+ or Nedd4-2−/− mice. Data are
normalized to tbp levels and represent mean± S.E.M. for four mice per genotype.
*Po0.05. Scale bars: (a)= 50 μm, inset= 1 mm; (b) (vimentin, picrosirius red and
SMA)= 100 μm, (KIM-1)= 50 μm
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NEDD4-2 expression within the distal nephron including the
collecting ducts, indicated by overlapping expression with the
lectin marker, dolichos biflorus agglutinin (DBA) (Figure 2c).
Importantly, NEDD4-2 expression was completely abolished
in the distal renal tubule of Nedd4-2Ksp1.3 kidneys.
Nedd4-2 ablation in renal tubules leads to renal pathol-
ogy. Nedd4-2Ksp1.3 revealed a similar progressive renal
pathology to the global Nedd4-2−/− mice, with a slightly later
onset. Macroscopic analysis revealed only minor differences
between control and Nedd4-2Ksp1.3 kidneys at P20 progres-
sing to mild changes at P40 evident by an irregular border
and small areas of disorganized tissue (Figure 3a). At
6 months, the kidneys appeared pale with small cysts in the
cortex and a hydronephrotic renal pelvis. Histological staining
showed increased tissue disorganization, tubule enlargement
and fibrosis, starting from small isolated regions at P20 to
larger fibrotic regions radiating in from the cortex at 6 months
(Figure 3b). Closer analysis of Nedd4-2Ksp1.3 mice at P40
showed enlarged tubules, with thinning or hypercellular
epithelium, necrotic cellular debris and significant collagen
deposition throughout the cortex and medulla as visualized
by picrosirius red staining (Figures 4a and b). Consistent with
this result, mRNA levels of Col1a1 were higher in
Nedd4-2Ksp1.3 mice (Figures 4d). Similar to the Nedd4-2−/−
mice, vimentin, SMA and KIM-1 expression were also
increased demonstrating kidney injury (Figures 4c and d
and Supplementary Figure 2). Immune cell infiltration was
apparent in the Nedd4-2Ksp1.3 kidney parenchyma, as seen
by immunostaining for the T-lymphocyte marker, CD3
(Figures 4e and f).
Active caspase-3 staining was used to determine whether
tubule epithelial cells were undergoing apoptosis. Figures 4g
and h show a significant increase in the number of cleaved
caspase-3-positive cells in Nedd4-2Ksp1.3 kidneys compared
with controls. Apoptotic cells were evident lining the tubules
and also accumulating in the enlarged tubular lumens,
detectable as early as P20 (Supplementary Figures 3a
and b). In addition, some tubular epithelial cells also appeared
swollen with enlarged nuclei, indicating necrotic changes
to the lining epithelium in the absence of NEDD4-2
(Supplementary Figure 3c). Loss of tubule epithelial cells at
an early age indicates that this may be an early manifestation

















































Figure 2 Generation of the renal-tubule-specific Nedd4-2 KO mice. (a) Semiquantitative immunoblot showing reduced NEDD4-2 expression in Nedd4-2Ksp1.3 versus control
mice at P40. Quantitated in (b) relative to β-actin expression to show an average reduction of ~ 50% with remaining NEDD4-2 likely due to expression within the renal corpuscle,
blood vessels and any other cells that do not express cadherin-16 but express NEDD4-2.12,13 (c) Immunohistochemical staining demonstrated high NEDD4-2 (green) expression
within the distal nephron of control mice, including the collecting ducts as indicated by overlapping expression with the lectin marker, DBA (red). Importantly, NEDD4-2 expression
was completely abolished in the distal renal tubule of Nedd4-2Ksp1.3 kidneys. Scale bars: (c)= 50 μm. *Po0.05
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Nedd4-2 deficiency leads to increased expression of
ENaC and NCC. We next wanted to determine whether the
levels of ENaC and NCC are altered in Nedd4-2Ksp1.3 kidneys
and could contribute to the renal disease observed in Nedd4-
2-deficient animals. During the process of maturation, all
three subunits of ENaC (α, β and γ) are post-translationally
modified. The α and γ subunits are processed by proteolytic
cleavage to their mature forms, and the β-subunit undergoes
glycoprotein processing.14,15 It is the mature ENaC com-
plexes that are predominantly localized at the plasma
membrane where they are regulated by NEDD4-2.16 Immu-
nostaining of Nedd4-2Ksp1.3 kidneys at P40 demonstrated
increased expression of all three ENaC subunits in the
collecting ducts (Figures 5a). Semiquantitative analysis by
immunoblot demonstrated upregulation of the mature forms
of the ENaC subunits, and no change in the levels of the full-
length, unprocessed forms, indicating that the loss of
NEDD4-2 expression in renal tubules results in increased
levels of mature ENaC at the plasma membrane (Figures 5b
and c). Interestingly, cells with high ENaC expression could
be seen lining dilated tubules and accumulating within the
lumens (Figures 5d).
We next examined the levels of NCC in Nedd4-2Ksp1.3
kidneys at P40. Immunostaining indicated higher levels of
NCC protein in Nedd4-2Ksp1.3 kidneys compared with control
(Figures 5e and f). Immunoblot analysis of Nedd4-2Ksp1.3
whole kidney lysates showed a similar increase in NCC
expression (Figures 5g and h), confirming previous findings
that NCC is regulated by NEDD4-2.4
Increased BP and salt reabsorption in Nedd4-2Ksp1.3
mice. Nedd4-2Ksp1.3 mice had increased blood Na+ concen-
tration, reduced blood K+ concentration and increased K+
excretion on a standard laboratory diet (Table 1), which has
not been previously observed in other Nedd4-2 KO models,
even on a high-salt diet.7,8 Nedd4-2Ksp1.3 mice also produced
more urine with a significantly lower osmolarity than their
control counterparts, possibly as a result of the increased Na+
reabsorption. Glomerular filtration rate (GFR) at 6 months
was unchanged compared with controls. Importantly, diastolic
(DBP) and systolic BP (SBP) were significantly higher in
Nedd4-2Ksp1.3 mice and blood aldosterone levels were
reduced (Figure 6). Aldosterone has a central role in Na+
conservation in the body and is regulated by the blood serum
levels of K+ and inversely by the levels of Na+. Low
aldosterone levels therefore indicate increased Na+/reduced
K+ retention in Nedd4-2Ksp1.3 mice even on a normal
laboratory diet. Taken together, these results demonstrate
the critical role of NEDD4-2 in regulating Na+ and K+ levels in
the blood.
Kidney damage is reduced by inhibition of ENaC. To
determine if ENaC and NCC could give rise to the kidney
damage, we treated mice with either amiloride (a specific
inhibitor of ENaC) or hydrochlorothiazide (HCTZ; to block
NCC) from P20 (weaning) until P41 (Figure 7a). Blood
aldosterone was significantly increased upon treatment with
amiloride in both controls and Nedd4-2Ksp1.3 mice
(Figure 7b), correlating with the expected effects of amiloride
Nedd4-2Ksp1.3Control 









Figure 3 Disease progression in Nedd4-2Ksp1.3 mice compared with Nedd4-2−/− and control mice. (a) Macroscopic images of Nedd4-2Ksp1.3 kidneys at P20, 40 and
6 months show disease progression. Indentations in the cortex are obvious at P40 and 6 months, and hydronephrosis develops only by 6 months (arrow). (b) Hematoxylin–eosin
(H&E) shows regions of kidney damage in Nedd4-2−/− kidneys at P20, compared with time course of disease progression in Nedd4-2Ksp1.3 kidneys (areas of damage are outlined
in red). Scale bars: (a)= 5 μm and (b)= 500 μm
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to block ENaC-mediated Na+ reabsorption. In untreated
Nedd4-2Ksp1.3 kidneys, there was a significant increase
in expression levels of Vim and Kim-1 when compared with
untreated controls, as detected by qRT-PCR (Figures 7c and
d). Importantly, in Nedd4-2Ksp1.3 P40 kidneys amiloride
treatment reduced the expression of both Vim and Kim-1.
These data suggest that inhibiting ENaC activity with
amiloride was able to alleviate the disease phenotype. On
the contrary, HCTZ treatment had little beneficial effect in
alleviating the kidney pathology. These results were sup-
ported by immunostaining for KIM-1 (Figures 7e and f). Taken
together, these data demonstrate for the first time that a
lack of NEDD4-2 increases Na+ reabsorption through
increased expression and activity of ENaC, and that this

















































































































































































Figure 4 Progressive kidney injury in kidney-specific Nedd4-2 KOmice. (a) Representative hematoxylin–eosin (H&E) images show enlarged tubules (black asterisk), thinning
of lining epithelium (open arrowhead), cellular debris within tubules (black arrows) and mesenchyme infiltration (black arrowhead) in P40 Nedd4-2Ksp1.3 mice. (b) Picrosirius red
staining demonstrates fibrosis in Nedd4-2Ksp1.3 kidneys (red). (c) Immunostaining shows increased expression of vimentin, SMA and Kim-1. (d) Increased gene expression for
markers of kidney injury at P40, including collagen (encoded by Col1a1), vimentin (Vim), SMA (Acta2) and Kim-1, determined by qRT-PCR. Only Kim-1 levels were significantly
altered at P20. Data are normalized to tbp levels and represent mean± s.e.m. for four mice per genotype. (e) Immune cell infiltration demonstrated by staining for CD3
(T-lymphocyte marker; and quantitated in (f)). (g and h) Immunostaining and quantitation of cleaved caspase-3-expressing cells shows apoptotic cells within tubules (white
asterisk) and lining epithelia (white arrows) of Nedd4-2Ksp1.3 kidneys at P40. (f and h) n= 4 per genotype. *Po0.05, **Po0.01, ***Po0.005 and ****Po0.001. Scale bars:
(a)= 50 μm, inset= 1 mm; (b)= 100 μm; (c) vimentin and SMA= 100 μm, Kim-1= 50 μm; (e and g)= 50 μm. fov, Field of view; NS= not significant (P40.05)
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Discussion
In this study, we have identified a novel link between
Nedd4-2 deficiency and nephropathy. We report for the first
time that deletion of Nedd4-2 in the kidney results in a
progressive kidney pathology characterized by renal fibrosis,
cortical cysts, inflammation and tubular epithelial cell apop-


















































































































































































Figure 5 Increased expression of active ENaC and NCC in P40 Nedd4-2Ksp1.3 mice. (a) Representative images showing increased α, β and γ ENaC subunits in Nedd4-
2Ksp1.3 kidneys also demonstrated by western blot (b) and quantified in (c). Note that only the mature forms of each subunit (cleaved and/or post-translationally modified) are
upregulated in Nedd4-2Ksp1.3mice. (d) Representative images show β ENaC (green) localized to the damaged epithelium (arrows) and cellular debris inside tubules (arrowheads)
in Nedd4-2Ksp1.31 kidneys. (e–h) NCC is upregulated in Nedd4-2Ksp1.3 kidneys as shown by immunohistochemistry in (e), quantitated in (f), and by immunoblot analysis (g and h).
Data are presented as mean± s.e.m. (f) n= 3 per genotype. *Po0.05, **Po0.01 and ***Po0.005. Scale bars: (a and e)= 25 μm (P40), (d) (top)= 25 μm,
(bottom)= 12.5 μm (P40)
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regulation of salt uptake via ENaC, even on a standard
laboratory diet.
Absence of Nedd4-2 results in kidney damage. As
described previously, most Nedd4-2−/− mice die perinatally
from respiratory distress.5 However, the few Nedd4-2−/−
mice that survive display progressive kidney damage
developing shortly after birth, with pathological features
similar to those commonly observed in patients with nephro-
pathies, such as fibrosis, cortical cysts, enlarged tubules
and cellular casts.17 Given the early postnatal lethality of
Nedd4-2−/− mice, we generated a renal-tubule-specific line
(Nedd4-2Ksp1.3) to investigate the cause of this kidney
damage. Nedd4-2Ksp1.3 mice display a progressive renal
pathology similar to the global Nedd4-2−/− mice, charac-
terized by significant tubular epithelial cell apoptosis and
fibrosis. By 6 months of age, Nedd4-2Ksp1.3 mice develop
prominent phenotypes of chronic kidney disease (CKD),
including hydronephrosis, polyuria and polydipsia. Nedd4-
2Ksp1.3 mice display increased serum Na+ levels and
increased K+ excretion, as well as high BP and low
aldosterone, which are all indicative of increased Na+
retention. Somewhat surprisingly Nedd4-2Ksp1.3 mice
maintained normal GFR at 6 months old, which is most likely
due to remaining Nedd4-2 expression in the glomerulus and
the progressive nature of the disease.
Table 1 Urine and plasma electrolytes in control and tubule-specific Nedd4-2Ksp1.3 mice at 6 months
Control Nedd4-2Ksp1.3 P-value
Body weight (g) 33.838± 1.0192 [5] 27.22±0.6788 [7]* 0.025
Intake
Food (g/g BW/24h) 0.085± 0.007 [5] 0.182±0.016 [7]* 0.013
Water (ml/g BW/24r) 0.164± 0.034 [5] 0.427±0.113 [7]* 0.018
Output
Feces (g/g BW/24 h) 0.023± 0.003 [5] 0.059±0.008 [7]* 0.025
Urine (ml/g BW/24 h) 0.033± 0.005 [5] 0.241±0.083 [7]* 0.025
Na+ excretion (μmol/24 h) 124.824± 22.630 [5] 125.156±26.725 [7] 0.631
Na+/Cr (103) 29.740± 2.517 [5] 29.664±3.750 [7] 0.631
K+ excretion (μmol/24h) 239.096± 28.534 [5] 359.383±48.426 [7] 0.070
K+/Cr (103) 59.050± 5.659 [5] 87.204±6.161 [7]* 0.010
Na+/K+ 0.522± 0.063 [5] 0.339±0.015 [7]* 0.030
Ca2
+
excretion (μmol/24h) 2.51635± 0.5 [3] 15.8835±1.9629 [7]* 0.017
Ca2
+
/Cr (103) 0.61869± 0.0063 [3] 4.627573±1.2878 [7]* 0.017
Urea excretion (μmol/24h) 1212.949± 169.696 [5] 1608.448±202.021 [7] 0.260
Urea/Cr (103) 295.483± 26.187 [5] 389.929±22.714 [7]* 0.048
Protein excretion (μg/24h) 3200.755± 666.685 [5] 2421.292±388.522 [7] 0.429
Protein/Cr (103) 825.425± 157.029 [5] 608.037±94.994 [7] 0.268
GFR (ml/g BW/24 h) 7.055± 1.108 [5] 7.371±0.888 [7] 0.710
Plasma
Na+ (mM) 147.600± 0.454 [24] 152.600±0.832 [16]*** o0.0001
K+ (mM) 3.736± 0.097 [24] 2.731±0.131 [16]*** o0.0001
Values are given as average± s.e.m. Number of mice are indicated in square brackets. P-values were determined using a Mann–Whitney test for non-normally

















































































































Figure 6 Nedd4-2Ksp1.3 mice have increased BP. (a) SBP and DBP of 6-month-old control and Nedd4-2Ksp1.3 mice. (b and c) Blood serum aldosterone levels were
significantly reduced in the Nedd4-2Ksp1.3 mice as compared with the control mice at the age of P40 (b) and 6 months (c). All mice were fed a standard laboratory diet. BP was
recorded from six to seven mice per genotype (control and Nedd4-2Ksp1.3) and gender. ****Po0.001
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Hypertension is known to contribute to kidney damage and
CKD.18 In both Nedd4-2−/− and Nedd4-2Ksp1.3 mice, kidney
damage begins soon after birth indicating that this pathology
is unlikely to be a secondary effect of hypertension.
Furthermore, additional models of Nedd4-2 deletion, which
exhibit a similar degree of hypertension, display no evidence
of kidney damage.7,8 These data suggest that the kidney
pathology observed in Nedd4-2 KO mice is due to a primary
effect on the tubular epithelia rather than as a result of
hypertension.
Kidney pathology caused by increased ENaC expres-
sion. Importantly, our Nedd4-2 KO mice develop kidney
damage on a standard laboratory diet, and the increased
Na+ reabsorption appears to be due, at least in part, to
increased levels of ENaC on the plasma membrane. Indeed,
we observed greater expression of the active forms of all
three ENaC subunits in the collecting ducts of Nedd4-2Ksp1.3
kidneys. In addition, we also observed a significant increase
in levels of NCC, which was noted in the Nedd4LPax8/LC1
model.8 The discrepancy in ENaC expression levels between
different Nedd4-2 mutant mouse models can be explained by
some expression of functional Nedd4-2 splice variants in
other Nedd4-2 mutant mouse lines.5 In our Nedd4-2Ksp1.3
mice, no functional NEDD4-2 can be expressed given that the
HECT domain is targeted.
The significance of increased levels of active ENaC in the
development of kidney disease in Nedd4-2Ksp1.3 mice is clear
from our data showing that amiloride treatment reduces renal
damage. Thus, increased functional ENaC at the plasma
membrane appears to be a contributing factor to the
development of kidney disease. Indeed, ENaC has been
implicated in the development of kidney damage in Dahl
salt-sensitive rats that develop hypertension and renal
damage after 4 weeks on a high-salt diet.19,20
In our Nedd4-2Ksp1.3 mice, inhibition of NCC alone (with
HCTZ) was not able to rescue the disease phenotype in our
Nedd4-2Ksp1.3 mice, suggesting that ENaC, and not NCC, is a
major contributor to the disease. Administration of amiloride,
however, did not fully rescue the kidney damage seen in
Nedd4-2Ksp1.3 mice. We therefore hypothesize that in addition
to increased Na+ absorption by ENaC, other NEDD4-2-
regulated mechanisms may contribute to the renal pathology
seen in Nedd4-2-deficient animals.
Clinical significance of NEDD4-2 in salt induced kidney
damage. The effect of Nedd4-2 deficiency in renal patho-
logy has not been previously characterized. There is
Figure 7 Treatment of Nedd4-2Ksp1.3 mice with diuretic drugs to block ENaC and NCC variably affects kidney damage. (a) Time course of treatment from P20 until
P40. Drugs were added to the drinking water daily: amiloride (2 mg/kg) and HCTZ (10 mg/kg). (b) Blood aldosterone levels are shown for all treatment groups at P40.
Amiloride treatment increases levels of aldosterone, as expected. (c) qRT-PCR data showing Vimentin and Kim-1 expression levels in control and Nedd4-2Ksp1.3
kidneys, administered with diuretic drugs in the tap water. (e and f) Representative images of Kim-1 immunostaining showing areas of kidney damage in the cortex in
untreated and treated mice (e), and the result of quantitation (f). (b–d) n= 9–14. (f) Samples were randomly selected from drug treatment experiment; n= 4–6 for control
untreated and Nedd4-2Ksp1.3 amiloride and HCTZ treated, n= 11 for Nedd4-2Ksp1.3 untreated (one dot represents one mouse). *Po0.05, **Po0.01, ***Po0.005 and
****Po0.001. Data are presented as mean± s.d. One-way analysis of variance (ANOVA) with Bonferroni’s post-test for comparison between multiple groups was used.
Scale bar: (c)= 500 μm
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evidence that Nedd4-2 contributes to salt-sensitive hyperten-
sion in humans, as multiple single-nucleotide polymorphisms
(SNPs) in this gene have been linked to increased ENaC
expression and hypertension.21–25 However, their possible
role in kidney disease has not been reported. In a previous
study assessing NEDD4L variants in hypertension, two
patients with a nonsynonymous variant of NEDD4L were
also found to have end-stage renal disease (ESRD).26 Thus,
SNPs of NEDD4L can lead to hypertension, as well as
contribute to renal diseases in patients, similar to that
observed in the Nedd4-2−/− and Nedd4-2Ksp1.3 mice.
Conclusions
Approximately 1 in 10 people worldwide suffer from varying
degrees of CKD, and those with hypertension or diabetes are
at even higher risk.27 In addition, CKD can itself contribute to
hypertension and cardiovascular disease further fueling the
burden of CKD on healthcare systems worldwide.28 Acute
kidney injury can initiate the onset of chronic and ESRD29,30
and is therefore an important focus for early intervention to
limit kidney pathology. NEDD4-2 is a critical regulator of
Na+ ion channels along the nephron, and polymorphisms in
the human NEDD4L gene are associated with salt-sensitive
hypertension and kidney disease. This makes NEDD4-2, and
proteins that may regulate it, important targets for the
development of therapeutics for improved health care of
patients with kidney disease. The studies reported here
provide new data toward the understanding of the function of
NEDD4-2, its critical role in Na+ homeostasis, and the
contribution of increased Na+ reabsorption to renal disease.
Materials and Methods
Mouse lines. Global Nedd4-2−/− mice were generated in our laboratory
previously.5 Kidney-specific inactivation of Nedd4-2 was achieved by crossing the
Nedd4-2-floxed line (Nedd4-2fl/fl)10 with the Ksp-Cre transgenic strain from Peter
Igarashi's laboratory (obtained through Christina Mitchell).12 Homozygous Nedd4-2-
floxed mice (Nedd4-2fl/fl) were crossed with heterozygous mice expressing the
Ksp1.3-Cre transgene. From the filial (F) 1 progeny, litters with heterozygous
deletion of Nedd4-2 gene that harbored the Ksp1.3-Cre transgene (Ksp1.3-Cre;
Nedd4-2fl/+) were selected and further crossed with Nedd4-2fl/fl mice to obtain
mice expressing complete deletion of Nedd4-2 in the F2 progeny (Ksp1.3-Cre;
Nedd4-2fl/fl), referred to as Nedd4-2Ksp1.3 mice. Nedd4-2−/− (C57BL/6 J) and
Nedd4-2Ksp1.3 (C57BL/6 J) mice were bred at the SA Pathology Animal Facility
(Adelaide, Australia) under specific pathogen-free conditions. All animal studies
were approved by the institutional animal ethics and biosafety committees at SA
Pathology, and were carried out according to the National Health and Medical
Research Council guidelines.
For tissue collection, mice were anesthetized and blood collected by cardiac
puncture. Animals were then quickly killed by cervical dislocation. Kidneys were
removed and the fibrous capsule dissected off. One kidney was snap frozen in liquid
nitrogen, and the other was cut in half in the coronal plane and immersion fixed in
Histochoice (ProSciTech, Kirwan, QLD, Australia) for 48 h at 4 °C. One-half of the
kidney was paraffin embedded and the other half was embedded in OCT for frozen
sections.
Drug treatment studies. For drug treatment studies, mice were treated with
amiloride (Sigma-Aldrich, St. Louis, MO, USA; 2 mg/kg per day: 14 mg/l)31 or HCTZ
(Sigma-Aldrich; 10 mg/kg per day: 67 mg/l)32 in the drinking water. Treatment began
after weaning at P20, with water changed daily for 21 days. Animals were
anesthetized for blood and tissue collection as above. During treatment, mice were
group housed in standard conditions with free access to food and water and
monitored daily.
Metabolic cage studies. Male, 6-month-old Nedd4-2Ksp1.3 and control
littermates were housed in metabolic cages for 24 h following three training
sessions of 6 h each. Mice were provided ad libitum access to deionized drinking
water and standard pelleted chow, and urine was collected every 5 h. At the end of
the experiment, blood and tissue samples were taken as described above.
Histological analysis. Kidney tissues fixed in histochoice were embedded
in paraffin and 5-μm sections were cut using a paraffin microtome. The sections
were mounted on glass slides, deparaffinized with xylene, dehydrated through
graded series of ethanol and stained with hematoxylin–eosin. To evaluate collagen
deposition using picrosirius red, slides were stained for 1 h in saturated picric acid
with 0.1% Direct Red 80 (Sigma-Aldrich), and then washed in 0.01 N hydrochloric
acid for 2 min. Digital images were acquired by using a NanoZoomer Imager
(Hamamatsu Photonics K. K., Japan).
Antibodies and immunohistochemistry. Paraffin sections (5 μm) were
deparaffinized and hydrated in a graded ethanol series. Heat-mediated antigen
retrieval was carried out by boiling for 10 min in 10 mM citric acid solution (pH 6).
Tissue sections were blocked with 10% goat serum. Primary antibodies used were:
rabbit anti-αENaC and rabbit anti-γENaC;33 rabbit anti-βENaC;5 fluorescein-
conjugated Lotus tetragonolobus agglutinin (cat. no. FL-1321; Vector Laboratories,
Burlingame, CA, USA); rhodamine-labeled DBA (cat. no. RL-1032; Vector
Laboratories); FITC-conjugated mouse anti-SMA (cat. no. F3777; Sigma-Aldrich);
rabbit anti-vimentin (cat. no. ab92547; Abcam, Cambridge, UK); rabbit anti-NCC
(cat. no. ab3553; Abcam); rabbit anti-cleaved caspase-3 (cat. no. 9661 S; Cell
signaling Technologies, Danvers, MA, USA); rat anti-Kim-1 (cat. no. MAB1817; R&D
Systems, Minneapolis, MN, USA). Immunostainings for Kim-1 and all ENaC
subunits were carried out on frozen sections (14 μm). For colorimetric staining,
endogenous peroxidase was blocked by incubation in 3% hydrogen peroxide before
primary antibody addition, sections were incubated with the corresponding
biotinylated secondary antibodies and sequentially incubated in ABC-Peroxidase
Solution according to the manufacturer’s protocol (Thermo Fisher Scientific,
Waltham, MA, USA), before being developed with 3,3′-diaminobenzidine
(DAB; Sigma-Aldrich). Sections were lightly counterstained with hematoxylin, and
then dehydrated and mounted. For fluorescence staining, tissue sections were
incubated with the corresponding fluorescently tagged secondary antibodies
(AlexaFluor-488 or -568; Thermo Fisher Scientific), counterstained with DAPI and
mounted in Prolong Gold Antifade reagent (Thermo Fisher Scientific). Stained
samples were imaged using an LSM 700 confocal microscope using Zen 2011
(Black Edition) version 8.1.5.484 (Carl Zeiss Microscopy, Jena, Germany) or
Nanozoomer Imager (Hamamatsu Photonics K. K., Japan). Image analysis was
carried out using ImageJ (NIH, Bethesda, MD, USA), Photoshop and Adobe Image
Suite (Adobe, San Jose, CA, USA) Software.
Quantification. Cleaved caspase-3-positive or CD3-positive cells were counted
in eight random cortical fields from four kidneys of each genotype at x20
magnification. Quantitation of total fluorescence from NCC-positive cells was carried
out from 4–6 random fields in the cortex of three mice each for control and Nedd4-
2Ksp1.3 kidneys at x100 magnification. Total fluorescence levels for each image was
measured using ImageJ (NIH). Percentage area of Kim-1-positive staining was
measured in the cortex and medulla of drug-treated and -untreated mice. Frozen
sections (14 μm) from at least six mice per group were immunostained for Kim-1
and then developed using DAB. Each section was then imaged on the Nanozoomer
Imager and the percentage area of Kim-1 staining in the cortex and medulla was
quantitated using ImageJ (NIH).
Immunoblotting. Kidneys were lysed in ice-cold extraction buffer at pH 7.5
(50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.27 M sucrose, 0.1%
β-mercaptoethanol and HALT protease and phosphatase inhibitor cocktail; Thermo
Fisher Scientific). Tissue was homogenized, frozen in liquid nitrogen, immediately
thawed and incubated at 4 °C on a nutator for 30 min and centrifuged at 13 000 r.p.
m. for 5 min. Supernatant protein (100 μg) was combined with protein load buffer
(100 mM Tris-HCl, pH 6.8, 200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20%
glycerol), heated at 95 °C for 5 min, loaded onto 4–20% precast SDS-PAGE gels
(Bio-Rad, Hercules, CA, USA) and transferred to PVDF membrane using the Trans-
blot Turbo Instrument (Bio-Rad). Membranes were blocked with 1% skim milk in
TBS-T (Tris-buffered saline/0.05% Tween-20) and primary antibodies were added:
rabbit anti-Nedd4-2,34 mouse anti-β-actin (clone AC15; Sigma-Aldrich), or ENaC
and NCC antibodies described above. HRP secondary antibodies were added
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(Merck Millipore, Billerica, MA, USA) and developed with a ECL Prime substrate
(GE Healthcare, Paramatta, NSW, Australia) on a ChemiDoc Touch Imager (Bio-
Rad).
Real-time quantitative PCR. Total RNA was isolated from kidneys using
TRIzol Reagent (Thermo Fisher Scientific) and RNA was reverse-transcribed with a
High Capacity cDNA Reverse Transcription Kit (Applied Biosciences, Foster city,
CA, USA). qRT-PCR was performed and analyzed as described,35 where all data
are normalized to tbp (TATA box-binding protein) levels. Primer sequences are
detailed in Supplementary Table 1.
BP measurements. BP was measured by a tail cuff system (CODA Monitor;
Kent Scientific Corporation, Torrington, CT, USA) as described previously.36 Briefly,
6-month-old mice were placed into a plastic tube restrainer, BP recording cuffs were
placed over the tail and the mice were allowed to adapt to the restrainer for 5 min.
BP was then measured for 10 acclimation cycles followed by 25–30 measurement
cycles. Heating pads were used to keep the mice warm throughout the experiment
to ensure sufficient blood flow to the tail. Blood pressure was recorded from six to
seven mice per genotype (control and Nedd4-2Ksp1.3) and gender.
Electrolytes and aldosterone. Electrolytes and aldosterone levels in blood
and urine were carried out by SA Pathology. Urinary and plasma Na+, K+, Cl− and
creatinine were measured using an Advia 2400 Chemistry System (Siemens,
Bayswater, VIC, Australia), and urine osmolality was measured with an Advanced
3320 Osmometer (Advanced Instruments, Thermo Fisher Scientific, Waltham, MA,
USA). Plasma aldosterone levels were measured using a Liaison Aldosterone Kit
and a Chemiluminescent Analyzer (Diasorin, Saluggia, Italy). GFR was estimated
based on creatinine clearance using a standard formula: GFR= urine flow x [urine
creatinine]/[plasma creatinine].37
Statistical analysis of data. Statistical analysis was performed using
GraphPad Prism software, version 6.0 (San Diego, CA, USA). One-way ANOVA with
Bonferroni’s post-test was used to assess rescue of kidney injury by qRT-PCR after
treatment with diuretics in control and Nedd4-2Ksp1.3 mice. Metabolic cage data and
cleaved caspase-3 quantitation was assessed using a Mann–Whitney test for non-
normally distributed data. Remaining data were analyzed using unpaired two-tailed
Student’s t-test with Welch’s correction, Nedd4-2Ksp1.3 versus controls. A P-value of
≤ 0.05 was considered significant. All values are presented as mean± s.e.m. unless
otherwise stated.
Study approval. All experimental procedures were approved by the SA
Pathology/CALHN animal ethics committee and carried out in accordance with the
local animal welfare act.
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